Jonathan Corren, MD. INC /ID# 208987

Los Angeles, California 90025-4749

0 studies enrolling now · 1 studies all time

What they study most

Atopic Dermatitis

Studies at this site

• A Study to Compare Safety and Efficacy of Upadacitinib to Dupilumab in Adult Participants With Moderate to Severe Atopic Dermatitis — Completed